Physician profile
David Levitsky
NPI 1841395183
$7,186.34
in general payments reported to CMS, 2019-2025
16 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,257 · 2020: $1,483 · 2021: $2,569 · 2022: $88.03 · 2023: $369 · 2024: $201 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $789.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,908.28 | 2019-2020 | |
| Stryker Corporation | $2,083.19 | 2019-2024 | Easyfuse, Ortholoc 3di, Citrefix |
| Paragon 28, INC. | $681.85 | 2019-2025 | Avitus Bone Graft Harvester, Bun-Yo-Matic, Apex 3d |
| Wright Medical Technology, INC. | $619.53 | 2019 | |
| Treace Medical Concepts, INC. | $565.66 | 2021-2025 | |
| Imbed Biosciences INC. | $84.70 | 2023 | |
| Bioventus LLC | $54.10 | 2022 | |
| Mimedx Group, INC. | $41.13 | 2025 | |
| Smith+Nephew, INC. | $29.88 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $25.65 | 2021 | |
| Osteomed LLC | $19.81 | 2021 | |
| Zimmer Biomet Holdings, INC. | $16.60 | 2020 | |
| Arthrex, INC. | $16.00 | 2020 | |
| Checkpoint Surgical, INC | $15.33 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.50 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Levitsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.